Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 29;13(4):903.
doi: 10.3390/life13040903.

Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications

Sofia Shtykalova  1   2 , Dmitriy Deviatkin  1   2 , Svetlana Freund  1   2 , Anna Egorova  1 , Anton Kiselev  1
Affiliations
Review

Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications

Sofia Shtykalova et al. Life (Basel). .

Abstract

Over the past decades, non-viral DNA and RNA delivery systems have been intensively studied as an alternative to viral vectors. Despite the most significant advantage over viruses, such as the lack of immunogenicity and cytotoxicity, the widespread use of non-viral carriers in clinical practice is still limited due to the insufficient efficacy associated with the difficulties of overcoming extracellular and intracellular barriers. Overcoming barriers by non-viral carriers is facilitated by their chemical structure, surface charge, as well as developed modifications. Currently, there are many different forms of non-viral carriers for various applications. This review aimed to summarize recent developments based on the essential requirements for non-viral carriers for gene therapy.

Keywords: endocytosis; exosomes; gene delivery; liposomes; microvesicles; nanomaterials; non-viral carriers; peptide-based carriers; polyplexes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Intracellular barriers to non-viral NA delivery.
Figure 2
Figure 2
Examples of polymeric carriers for non-viral NA delivery. Dots indicate the location of signed atoms (O, N).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Picanço-Castro V., Pereira C.G., Covas D.T., Porto G.S., Athanassiadou A., Figueiredo M.L. Emerging patent landscape for non-viral vectors used for gene therapy. Nat. Biotechnol. 2020;38:151–157. doi: 10.1038/s41587-019-0402-x. - DOI - PMC - PubMed
    1. Tong L., Liu D., Cao Z., Zheng N., Mao C., Liu S. Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review. Int. J. Mol. Sci. 2023;24:3375. doi: 10.3390/ijms24043375. - DOI - PMC - PubMed
    1. Wang Y., Bruggeman K.F., Franks S., Gautam V., Hodgetts S.I., Harvey A.R., Williams R.J., Nisbet D.R. Is Viral Vector Gene Delivery More Effective Using Biomaterials? Adv. Healthc. Mater. 2021;10:2001238. doi: 10.1002/adhm.202001238. - DOI - PubMed
    1. Grant-Serroukh D., Hunter M.R., Maeshima R., Tagalakis A.D., Aldossary A.M., Allahham N., Williams G.R., Edbrooke M., Desai A., Hart S.L. Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo. J. Control. Release. 2022;348:786–797. doi: 10.1016/j.jconrel.2022.06.018. - DOI - PubMed
    1. Xu S., Yang K., Li R., Zhang L. mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection. Int. J. Mol. Sci. 2020;21:6582. doi: 10.3390/ijms21186582. - DOI - PMC - PubMed

LinkOut - more resources